Brief: Preveceutical Initiates Preparation Of Proof-Of-Concept Preclinical Study For Its Diabetes & Obesity Dual Gene Therapy Program

Preveceutical Medical

04/12/2023 12:55

Dec 4 (Reuters) - Preveceutical Medical Inc  PREV.CD :
    * PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT
PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY
PROGRAM
    * PREVECEUTICAL MEDICAL INC - ANTICIPATE COMMENCING
PRECLINICAL
STUDIES IN EARLY 2024
    * PREVECEUTICAL MEDICAL INC: ALSO APPROACHED MULTIPLE
INVESTMENT
BANKERS AND INVESTORS TO PROVIDE FUNDING REQUIRED TO COMPLETE
PRECLINICAL STUDIES

Source text for Eikon:  ID:nCNWSHKSha 
Further company coverage:  PREV.CD 

 ((Reuters.Briefs@thomsonreuters.com;))